Current NDC auxiliary source row compounder:4085

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 72934-5402
Product Ndc: 72934-5402
Product Ndc Digits: 729345402
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Nynute
Proprietary Name Suffix: [empty]
Nonproprietary Name: 201019 LIDOCAINE 23% / TETRACAINE 7%
Dosage Form Name: OINTMENT
Route Name: TOPICAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: SKNV
Establishment Name: SKNV
Establishment Fei: [empty]
Substance Name: LIDOCAINE; TETRACAINE
Active Ingredients Info: 23 g/100 mL; 7 g/100 mL
History Active Ingredients Raw: LIDOCAINE; TETRACAINE
History Active Ingredients Info Raw: 23 g/100 mL; 7 g/100 mL
History Dosage Raw: OINTMENT
Dea Schedule: [empty]
Package Ndc Raw: 72934-5402-4
Package Ndc: 72934-5402-4
Package Ndc Digits: 7293454024
Package Ndc11: 72934540204
Package Description: 120 mL in 1 BOTTLE, PUMP (72934-5402-4)
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:4085
Source Row Number: 4085
Source Row Hash: 21902cf1120377e95614337964bed7e6e51c6c2773b39162b991a65eed33339c
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33

Exact raw FDA source fields#

{
    "ROUTENAME": "TOPICAL",
    "PRODUCTNDC": "72934-5402",
    "DEASCHEDULE": "",
    "LABELERNAME": "SKNV",
    "SUBSTANCENAME": "LIDOCAINE; TETRACAINE",
    "DOSAGEFORMNAME": "OINTMENT",
    "NDCPACKAGECODE": "72934-5402-4",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Nynute",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "201019 LIDOCAINE 23% / TETRACAINE 7%",
    "PACKAGEDESCRIPTION": "120 mL in 1 BOTTLE, PUMP (72934-5402-4) ",
    "ACTIVEINGREDIENTSINFO": "23 g/100 mL; 7 g/100 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:4085
Source Row Number: 4085
Status Scope: package
Lookup Ndc: 72934-5402-4
Lookup Ndc Digits: 7293454024
Product Ndc: 72934-5402
Product Ndc Digits: 729345402
Package Ndc: 72934-5402-4
Package Ndc Digits: 7293454024
Package Ndc11: 72934540204
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 21902cf1120377e95614337964bed7e6e51c6c2773b39162b991a65eed33339c
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33